Tumor PD-L1 expression was tested using primary antibody anti-PD-L1 (Abcam, ab205921, clone 28–8, at 1:30 dilution; 1 h 37 °C) following the manufacturer's protocol. This evidence concerns the gene CD274 and neoplasm.